News

Amyloid plaques impair astrocyte function to regulate brain vessels’ blood flow in Alzheimer’s disease. These are the findings from a study entitled “Vascular amyloidosis impairs the gliovascular unit in a mouse model of Alzheimer’s disease,” published in the journal Brain. In this study, the researchers investigated the role of…

University of California researchers recently showed that the targeting of a neurotransmitter involved in stress responses significantly reduced cellular and tissue damage while preventing the onset of cognitive impairment in a transgenic mice model of Alzheimer’s disease. The study, entitled “Corticotropin-releasing factor receptor-1 antagonism mitigates beta amyloid pathology…

In a new study entitled “Critical Flicker Fusion Predicts Executive Function in Younger and Older Adults,” a team of researchers developed a new device that allows for a precise assessment of an individuals’ visual processing speed, i.e., how fast can a person can understand visual information. This device is a…

Results from a recent study published in the Scandinavian Journal of Public Health show that mean healthcare costs of patients with Alzheimer’s disease (AD) are significantly higher than of a similar age without AD, starting to increase one year before diagnosis and peaking six months after the disease…

Everyone knows that exercise is good for you, both physically and mentally. Now, a new study suggests that physical activity may not only boost brainpower, it might even prevent Alzheimer’s disease. Researchers from St. Louis, Missouri, studied mice with an experimental form of Alzheimer’s disease and found that those mice doing the…

Neuroinflammation in the central nervous system is a known key event in Alzheimer’s pathogenesis and has long been proposed as a therapeutic target, but studies conducted in the early 2000s of potential anti-inflammatory treatments didn’t produce the hoped for outcomes. Now a renewed interest is emerging in Alzheimer’s disease (AD) treatments targeting neuroinflammation, still a…

Sometimes more is not necessarily better. This may especially be true of Alzheimer’s disease clinical studies, too many of which have been tried and failed, leading top scientists to question their design and execution. Better planning in the application of more promising approaches might make more sense — and improve a…

Results from a recent study presented at the 8th International Conference on Clinical Trials for Alzheimer’s Disease (CTAD) revealed that aerobic exercise improves brain function and reduces neurodegeneration markers in older adults at risk for Alzheimer’s disease (AD). Study results also indicate that aerobic exercise may be a potential disease-modifying intervention…

During the  8th International Conference on Clinical Trials for Alzheimer’s Disease (CTAD) held in Barcelona, Spain, data from the MAPT study of older adults with memory lapses was presented. This study suggested that the combination of a multi-domain nutritional and stimulation intervention plus an omega-3 fatty acid supplementation slows…

In a recent study published in the journal JAMDA, a team of researchers from the Institute of Psychiatry, Psychology & Neuroscience (IoPPN) at King’s College London determined that online games that challenge memory and cognitive skills could beneficially improve daily life for older people. The team demonstrated specifically…